These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 24886692
1. Spray dried amikacin powder for inhalation in cystic fibrosis patients: a quality by design approach for product construction. Belotti S, Rossi A, Colombo P, Bettini R, Rekkas D, Politis S, Colombo G, Balducci AG, Buttini F. Int J Pharm; 2014 Aug 25; 471(1-2):507-15. PubMed ID: 24886692 [Abstract] [Full Text] [Related]
2. Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation. Belotti S, Rossi A, Colombo P, Bettini R, Rekkas D, Politis S, Colombo G, Balducci AG, Buttini F. Eur J Pharm Biopharm; 2015 Jun 25; 93():165-72. PubMed ID: 25845771 [Abstract] [Full Text] [Related]
3. Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction. Kozáková J, Altay A, Ždímal V, Mašková L, Sonvico F, Quarta E, Rossi A, Buttini F, Colombo G. Drug Dev Ind Pharm; 2019 Oct 25; 45(10):1664-1673. PubMed ID: 31389270 [Abstract] [Full Text] [Related]
4. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery. Li X, Vogt FG, Hayes D, Mansour HM. Eur J Pharm Sci; 2014 Feb 14; 52():191-205. PubMed ID: 24215736 [Abstract] [Full Text] [Related]
5. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants. Cheow WS, Ng ML, Kho K, Hadinoto K. Int J Pharm; 2011 Feb 14; 404(1-2):289-300. PubMed ID: 21093560 [Abstract] [Full Text] [Related]
7. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols. Park CW, Li X, Vogt FG, Hayes D, Zwischenberger JB, Park ES, Mansour HM. Int J Pharm; 2013 Oct 15; 455(1-2):374-92. PubMed ID: 23820131 [Abstract] [Full Text] [Related]
9. Development of inhalable dry powder formulation of basic fibroblast growth factor. Ibrahim BM, Jun SW, Lee MY, Kang SH, Yeo Y. Int J Pharm; 2010 Jan 29; 385(1-2):66-72. PubMed ID: 19853028 [Abstract] [Full Text] [Related]
12. The Cyclops for pulmonary delivery of aminoglycosides; a new member of the Twincer™ family. Hoppentocht M, Akkerman OW, Hagedoorn P, Frijlink HW, de Boer AH. Eur J Pharm Biopharm; 2015 Feb 29; 90():8-15. PubMed ID: 25615881 [Abstract] [Full Text] [Related]
19. Non-steroidal anti-inflammatory drug for pulmonary administration: design and investigation of ketoprofen lysinate fine dry powders. Stigliani M, Aquino RP, Del Gaudio P, Mencherini T, Sansone F, Russo P. Int J Pharm; 2013 May 01; 448(1):198-204. PubMed ID: 23528281 [Abstract] [Full Text] [Related]